William Shakespeare wrote, “What’s past is prologue” in “The Tempest,” a thought profound enough to be engraved on the ...
It is an issue of equity – one that COM has been committed to improving despite already being lauded as a leader among state ...
Plan to proceed with execution of globally approved protocol for amezalpat in first-line HCC subject to additional resources or partnerships Matt Angel, Ph.D. to assume role of President and CEO and ...
All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T program Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR- Antagonist, Phase 3-ready) and ...
BRISBANE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- In a transaction designed to both expand its pipeline and extend its runway, Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest” or “the Company”), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results